Ben Beckley Joins RevHealth As CEO
In his most recent role, Beckley shepherded the combined rare disease and communications agency (formerly Ashfield Health) through a successful global merger and expanded its capabilities in omnichannel, patient experience and data by launching the proprietary technology, Gravity.ai. He has also held growth-focused leadership roles at Havas Health & You and PRECISIONeffect.
"RevHealth has a well established history in the traditional AOR and medcomms space, and has built a significant presence in patient advocacy and market access. It's rare to find all of these disciplines being built from within," said Beckley. "It's what our clients are looking for versus a traditional sister agency approach."
RevHealth is on a path of strategic growth following its 2022 acquisition by WindRose Health Investors. In addition to bringing on Beckley as CEO, they have unveiled a new brand look and feel that reflects the dynamic culture and talent of the agency.
"The top talent at RevHealth is the biggest attraction. It's rare to find this many innovators all in one place, with more announcements coming soon," said Beckley. "In a world where the right moment is everything to adoption, our unique approach to omnichannel, analytics and data will demonstrate how our industry can in fact change and be more in tune with consumer behaviors."
About RevHealth
Based in
CONTACT:
michelle@clfacollective.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ben-beckley-joins-revhealth-as-ceo-302048342.html
SOURCE RevHealth
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Eucalyptus Resources Reminds Shareholders to Vote GREEN, Warns TNR Gold Shareholders Against Threatened Disenfranchisement and Supplements Disclosure
- Salesforce in talks to acquire AI platform Listen Labs for $2 billion - report
- NOTICE TO DISREGARD -- AceUp
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share